# ShengYa Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shengya-bio

- Industry: Biotechnology
- Headquarters: Xiamen, China
- Latest round: Series B (Dec 8, 2025)
- Investors on record: 2

## About

Based in Xiamen, China and founded in 2018, ShengYa Biotechnology (Xiamen) Co., Ltd., trading as ShengYa Bio, is a biotechnology promotion and service company specializing in the research, development, and production of in vitro diagnostic reagents and equipment. In December 2025, ShengYa Bio raised a series B funding from new investors Shanghai Chengpu Investment and CDIB Capital Group.

The company provides in vitro diagnostic reagents and equipment.

The company's revenue is generated by selling in vitro diagnostic reagents and equipment.

The company will use the latest funding to accelerate product research and development and market expansion, further enhancing its competitiveness in the biomedical field.

## Funding rounds

- Series B, Dec 8, 2025 — CDIB Capital Group, Shanghai Chengpu Investment

## Investors

- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series B
- Shanghai Chengpu Investment (https://capitalatlas.ai/funds/shanghai-chengpu-investment) — Series B